Development
Lantern Pharma Inc.
LTRN
$3.32
-$0.11-3.21%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/31/2025
-
Ticker Report
5/31/2025
-
Ticker Report
5/30/2025
-
Ticker Report
5/30/2025
-
Ticker Report
5/30/2025
-
MarketBeat
5/30/2025
-
Insider Monkey
5/29/2025
-
GuruFocus
5/29/2025
-
GuruFocus
5/29/2025
-
The Fly
5/29/2025
-
Business Wire
5/20/2025
-
The Fly
5/16/2025
-
The Fly
5/16/2025
-
Insider Monkey
5/16/2025
-
TipRanks Financial Blog
5/15/2025
-
SeekingAlpha.com: All News
5/15/2025
-
SeekingAlpha
5/15/2025
-
Seeking Alpha: Transcripts
5/15/2025
-
SeekingAlpha
5/15/2025
-
GuruFocus
5/15/2025
-
GuruFocus
5/15/2025
-
Business Wire
5/12/2025
-
GuruFocus
5/12/2025
-
GuruFocus
5/12/2025
-
GuruFocus
5/12/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 277 1136
Address
1920 McKinney Avenue
Dallas, TX 75201
Dallas, TX 75201
Country
Year Founded
Business Description
Sector
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its product...
more